[1] MUELLER M M,VAN REMOORTEL H,MEYBOHM P,et al.Patient blood management:recommendations from the 2018 Frankfurt consensus conference[J]. JAMA,2019,321(10):983-997.
[2] SHANDER A,VAN AKEN H,COLOMINA M J,et al.Patient blood management in Europe[J].Br J Anaesth,2012,109(1):55-68.
[3] MARSHALL A,DAVIDSON A.Patient blood manageme nt in NHSBT[J].Br J Nurs,2020,29(18):1079-1081.
[4] BUTCHER A,RICHARDS T.Cornerstones of patient blood management in surgery[J].Transfus Med,2018,28(2):150-157.
[5] FOWLER A J,AHMAD T,ABBOTT T E F,et al. Association of preoperative anaemia with postoperative morbidity and mortality:an observational cohort study in low-,middle-,and high-income countries[J]. Br J Anaesth,2018,121(6):1227-1235.
[6] MUSALLAM K M,TAMIM H M,RICHARDS T,et al.Preoperative anaemia and postoperative outcomes in non-cardiac surgery:a retrospective cohort study[J]. Lancet,2011,378(9800):1396-1407.
[7] FERRARIS V A,HOCHSTETLER M,MARTIN J T,et al.Blood transfusion and adverse surgical outcomes:the good and the bad[J]. Surgery,2015,158(3):608-617.
[8] SHANDER A,BROWN J,LICKER M,et al.Standards and best practice for acute normovolemic hemodilution:evidence-based consensus recommendations[J]. J Cardiothorac Vasc Anesth,2020,34(7):1755-1760.
[9] GOODNOUGH L T,SHANDER A.Patient blood management[J]. Anesthesiology,2012,116(6):1367-1376.
[10] GOODNOUGH L T,MANIATIS A,EARNSHAW P,et al.Detection,evaluation,and management of preoperative anaemia in the elective orthopaedic surgical patient:NATA guidelines[J]. Br J Anaesth,2011,106(1):13-22.
[11] ABEYSIRI S,CHAU M,HIGHTON D,et al.Management of the patient presenting with anaemia in the preoperative setting[J]. Transfus Apher Sci,2019,58(4):392-396.
[12] SPAHN D R,BOUILLON B,CERNY V,et al.The European guideline on management of major bleeding and coagulopathy following trauma:fifth edition[J]. Crit Care,2019,23(1):98.
[13] PETERS J,PENDRY K.Patient blood management:an update of current guidance in clinical practice[J]. Br J Hosp Med (Lond),2017,78(2):88-95.
[14] GHADIMI K,LEVY J H,WELSBY I J.Perioperative management of the bleeding patient[J].Br J Anaesth,2016,117(suppl 3):iii18-iii30.
[15] KLEIN A A,ARNOLD P,BINGHAM R M,et al.AAGBI guidelines:the use of blood components and their alternatives 2016[J]. Anaesthesia,2016,71(7):829-842.
[16] ESTCOURT L J,BIRCHALL J,ALLARD S,et al.Guidelines for the use of platelet transfusions[J]. Br J Haematol,2017,176(3):365-394.
[17] ROSSAINT R,BOUILLON B,CERNY V,et al.The European guideline on management of major bleeding and coagulopathy following trauma:fourth edition[J]. Crit Care,2016,20(100.
[18] 中华人民共和国国家卫生和计划生育委员会,《临床输血技术规范》2000年版,[EB/OL][2001-11-8]. http://www.moh.gov.cn/mohyzs/s3589/200804/18676.shtml.
[19] SPYROPOULOS A C,AL-BADRI A,SHERWOOD M W,et al.Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery[J]. J Thromb Haemost,2016,14(5):875-885.
[20] SALPETER S R,BUCKLEY J S,CHATTERJEE S. Impact of more restrictive blood transfusion strategies on clinical outcomes:a meta-analysis and systematic review[J]. Am J Med,2014,127(2):124-131.e3.
[21] HOLST L B,PETERSEN M W,HAASE N,et al.Restrictive versus liberal transfusion strategy for red blood cell transfusion:systematic review of randomised trials with meta-analysis and trial sequential analysis[J]. BMJ,2015,350:h1354.
[22] KAUFMAN R M,DJULBEGOVIC B,GERNSHEIMER T,et al.Platelet transfusion:a clinical practice guideline from the AABB[J]. Ann Intern Med,2015,162(3):205-213.
[23] Goodnough LT, Monk TG.Autologous transfusion. In: Miller RD, editor. Miller’s anesthesia[M]. 6th edition. Philadelphia: Elsevier/Churchill Livingstone,2005, 1831-1844.
[24] AMERICAN Society of Anesthesiologists Task Force on Perioperative Blood Management. Practice guidelines for perioperative blood management:an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management[J]. Anesthesiology,2015,122(2):241-275.
[25] HÖHN L,SCHWEIZER A,LICKER M,et al. Absence of beneficial effect of acute normovolemic hemodilution combined with aprotinin on allogeneic blood transfusion requirements in cardiac surgery[J]. Anesthesiology,2002,96(2):276-282.
[26] CARDONE D,KLEIN A A.Perioperative blood conservation[J]. Eur J Anaesthesiol,2009,26(9):722-729.
[27] BRITISH COMMITTEE FOR STANDARDS IN HAEMATOLOGY T T F,BOULTON F E,JAMES V. Guidelines for policies on alternatives to allogeneic blood transfusion. 1. Predeposit autologous blood donation and transfusion[J]. Transfus Med,2007,17(5):354-365.
[28] LEAL-NOVAL S R,MUÑOZ M,ASUERO M,et al. Spanish Consensus Statement on alternatives to allogeneic blood transfusion:the 2013 update of the “Seville Document”[J]. Blood Transfus,2013,11(4):585-610.
[29] HENRY D A,CARLESS P A,MOXEY A J,et al. Pre-operative autologous donation for minimising perioperative allogeneic blood transfusion[J]. Cochrane Database Syst Rev,2002,2001(2):CD003602.
[30] SIKORSKI R A,RIZKALLA N A,YANG W W,et al.Autologous blood salvage in the era of patient blood management[J]. Vox Sang,2017,112(6):499-510.
[31] Carless P A,Henry D A,Moxey A J,et al. Cell salvage for minimising perioperative allogeneic blood transfusion[J]. Cochrane Database Syst Rev,2006(4):CD001888.
[32] YORKGITIS B K,RUGGIA-CHECK C,DUJON J E.Antiplatelet and anticoagulation medications and the surgical patient[J]. Am J Surg,2014,207(1):95-101.
[33] FILIPESCU D C,STEFAN M G,VALEANU L,et al.Perioperative management of antiplatelet therapy in noncardiac surgery[J]. Curr Opin Anaesthesiol,2020,33(3):454-462.
[34] DANIELS P R.Peri-procedural management of patients taking oral anticoagulants[J].BMJ,2015,351:h2391.
[35] DOHERTY J U,GLUCKMAN T J,HUCKER W J,et al.2017 ACC expert consensus decision pathway for periprocedural management of anticoagulation in patients with nonvalvular atrial fibrillation[J]. J Am Coll Cardiol,2017,69(7):871-898.
[36] BIRNIE D H,HEALEY J S,WELLS G A,et al.Pacemaker or defibrillator surgery without interruption of anticoagulation[J]. N Engl J Med,2013,368(22):2084-2093.
[37] SIEGAL D,YUDIN J,KAATZ S,et al.Periprocedural heparin bridging in patients receiving vitamin K antagonists:systematic review and meta-analysis of bleeding and thromboembolic rates[J]. Circulation,2012,126(13):1630-1639.
[38] ONO K,HIDAKA H,SATO M,et al.Preoperative continuation of aspirin administration in patients undergoing major abdominal malignancy surgery[J]. J Anesth,2019,33(1):90-95.
[39] DOUKETIS J D,HEALEY J S,BRUECKMANN M,et al.Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial[J]. Thromb Haemost,2015,113(3):625-632.
[40] MATHEW J G,SPYROPOULOS A C,YUSUF A,et al.Efficacy and safety of early parenteral anticoagulation as a bridge to warfarin after mechanical valve replacement[J]. Thromb Haemost,2014,112(6):1120-1128.
[41] BEYER-WESTENDORF J,GELBRICHT V,FÖRSTER K,et al. Peri-interventional management of novel oral anticoagulants in daily care:results from the prospective Dresden NOAC registry[J]. Eur Heart J,2014,35(28):1888-1896.
[42] POERAN J,RASUL R,SUZUKI S,et al.Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States:retrospective analysis of effectiveness and safety[J]. BMJ,2014,349(aug12 8):g4829. |
